These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30142511)

  • 1. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers.
    Raulf N; Lucarelli P; Thavaraj S; Brown S; Vicencio JM; Sauter T; Tavassoli M
    Eur J Cancer; 2018 Oct; 102():52-68. PubMed ID: 30142511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
    Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
    Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b.
    Álvarez-Teijeiro S; Menéndez ST; Villaronga MÁ; Pena-Alonso E; Rodrigo JP; Morgan RO; Granda-Díaz R; Salom C; Fernandez MP; García-Pedrero JM
    Sci Rep; 2017 Jul; 7(1):6790. PubMed ID: 28754915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
    Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
    Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation.
    Li Q; Liu W; Wang Z; Wang C; Ai Z
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34779491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation alters the cargo of exosomes released from squamous head and neck cancer cells to promote migration of recipient cells.
    Mutschelknaus L; Azimzadeh O; Heider T; Winkler K; Vetter M; Kell R; Tapio S; Merl-Pham J; Huber SM; Edalat L; Radulović V; Anastasov N; Atkinson MJ; Moertl S
    Sci Rep; 2017 Sep; 7(1):12423. PubMed ID: 28963552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.
    Belvedere R; Saggese P; Pessolano E; Memoli D; Bizzarro V; Rizzo F; Parente L; Weisz A; Petrella A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma.
    Zheng Y; Wang Z; Xiong X; Zhong Y; Zhang W; Dong Y; Li J; Zhu Z; Zhang W; Wu H; Gu W; Wu Y; Wang X; Song X
    J Cell Physiol; 2019 May; 234(5):5940-5952. PubMed ID: 30515785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
    Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
    PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.
    Yuan Y; Anbalagan D; Lee LH; Samy RP; Shanmugam MK; Kumar AP; Sethi G; Lobie PE; Lim LH
    Oncotarget; 2016 May; 7(19):27007-20. PubMed ID: 27105503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma.
    Han GH; Lu KJ; Huang JX; Zhang LX; Dai SB; Dai CL
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S667-S674. PubMed ID: 30249885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
    Nair S; Trummell HQ; Rajbhandari R; Thudi NK; Nozell SE; Warram JM; Willey CD; Yang ES; Placzek WJ; Bonner JA; Bredel M
    PLoS One; 2020; 15(2):e0229077. PubMed ID: 32069320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms.
    Han G; Lu K; Huang J; Ye J; Dai S; Ye Y; Zhang L
    Int J Mol Med; 2017 Feb; 39(2):357-363. PubMed ID: 28035369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status.
    Garcia Pedrero JM; Fernandez MP; Morgan RO; Herrero Zapatero A; Gonzalez MV; Suarez Nieto C; Rodrigo JP
    Am J Pathol; 2004 Jan; 164(1):73-9. PubMed ID: 14695321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.
    Rebucci M; Peixoto P; Dewitte A; Wattez N; De Nuncques MA; Rezvoy N; Vautravers-Dewas C; Buisine MP; Guerin E; Peyrat JP; Lartigau E; Lansiaux A
    Int J Oncol; 2011 Jan; 38(1):189-200. PubMed ID: 21109940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.